Literature DB >> 7074425

Effect of acetazolamide and furosemide on the production and composition of cerebrospinal fluid from the cat choroid plexus.

J M Melby, L C Miner, D J Reed.   

Abstract

The effect of acetazolamide and furosemide on choroid plexus (CP) production and electrolyte composition of cerebrospinal fluid (CSF) from the cat CP in situ was investigated. Both drugs decreased CSF production by the CP by 50--90% from a control rate of 0.53 microL . min-1 . mg-1 CP within 1.5--2.5 h after the start of drug treatment. The results were similar whether the drug was administered intravenously or applied directly to the CSF side of the CP. A number of experiments in which the effect of administering drugs via the chamber were studied were continued with the drugs removed by washing the preparation with drug-free artificial CSF and the responses measured. The results demonstrated that the effects of acetazolamide and furosemide were reversed during the 1st h following the washout. Both drugs decreased K concentration of nascent CSF when administered intravenously and furosemide also did so when administered on the CSF side of the CP. It is concluded from these and previous data that acetazolamide and furosemide markedly inhibit the transport mechanism(s) in the cat CP that are responsible for CP secretion which represents about 40--60% of the total CSF production and that K transport is also affected.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7074425     DOI: 10.1139/y82-059

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  11 in total

Review 1.  Molecular mechanisms of brain water transport.

Authors:  Nanna MacAulay
Journal:  Nat Rev Neurosci       Date:  2021-04-12       Impact factor: 34.870

Review 2.  Pediatric Pseudotumor Cerebri Syndrome: Diagnosis, Classification, and Underlying Pathophysiology.

Authors:  Claire A Sheldon; Grace L Paley; Shannon J Beres; Shana E McCormack; Grant T Liu
Journal:  Semin Pediatr Neurol       Date:  2017-04-07       Impact factor: 1.636

Review 3.  An integrated mechanism of pediatric pseudotumor cerebri syndrome: evidence of bioenergetic and hormonal regulation of cerebrospinal fluid dynamics.

Authors:  Claire A Sheldon; Young Joon Kwon; Grant T Liu; Shana E McCormack
Journal:  Pediatr Res       Date:  2014-11-24       Impact factor: 3.756

Review 4.  Water and solute secretion by the choroid plexus.

Authors:  Jeppe Praetorius
Journal:  Pflugers Arch       Date:  2006-11-21       Impact factor: 3.657

5.  Bumetanide decreases canine cerebrospinal fluid production. In vivo evidence for NaCl cotransport in the central nervous system.

Authors:  S Javaheri; K R Wagner
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

6.  Ethacrynic acid and furosemide alter Cl, K, and Na distribution between blood, choroid plexus, CSF, and brain.

Authors:  C E Johanson; V A Murphy; M Dyas
Journal:  Neurochem Res       Date:  1992-11       Impact factor: 3.996

Review 7.  Preclinical update on regulation of intracranial pressure in relation to idiopathic intracranial hypertension.

Authors:  Sajedeh Eftekhari; Connar Stanley James Westgate; Maria Schmidt Uldall; Rigmor Hoejland Jensen
Journal:  Fluids Barriers CNS       Date:  2019-11-26

Review 8.  Cerebrospinal fluid production by the choroid plexus: a century of barrier research revisited.

Authors:  Nanna MacAulay; Richard F Keep; Thomas Zeuthen
Journal:  Fluids Barriers CNS       Date:  2022-03-22

9.  Acetazolamide modulates intracranial pressure directly by its action on the cerebrospinal fluid secretion apparatus.

Authors:  Dagne Barbuskaite; Eva K Oernbo; Jonathan H Wardman; Trine L Toft-Bertelsen; Eller Conti; Søren N Andreassen; Niklas J Gerkau; Christine R Rose; Nanna MacAulay
Journal:  Fluids Barriers CNS       Date:  2022-06-29

10.  Topiramate is more effective than acetazolamide at lowering intracranial pressure.

Authors:  William J Scotton; Hannah F Botfield; Connar Sj Westgate; James L Mitchell; Andreas Yiangou; Maria S Uldall; Rigmor H Jensen; Alex J Sinclair
Journal:  Cephalalgia       Date:  2018-06-13       Impact factor: 6.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.